Facial recognition trained to keep watch over sedated hospital patients

Facial recognition technology can be used to monitor sedated patients in intensive care units, alerting healthcare workers when a patient is at risk of accidentally removing a breathing tube or engaging in other risky behavior.

The concept was proven out with a moderate level of accuracy—75%—in a Japanese study in which scientists trained an algorithm on 99 images from cameras aimed at the faces of 24 patients in the ICU.

The study was presented June 3 at the annual meeting of the European Society of Anaesthesiology in Vienna.

Lead author Akane Sato from Yokohama City University and colleagues tested their technique on 99 images of 24 post-op patients.

According to a press release disseminated from the conference, they built their tool to recognize signs of high-risk arm movement after analyzing data on facial expressions and eye movements.

Moderate to heavy sedation is common in ICU settings, they pointed out, and its use can make for difficult patient monitoring, especially when nursing units are staffed below optimal staffing levels.

“Various situations can put patients at risk, so our next step is to include additional high-risk situations in our analysis, and to develop an alert function to warn healthcare professionals of risky behavior,” Sato said. “Our end goal is to combine various sensing data such as vital signs with our images to develop a fully automated risk prediction system.”

The team said it will need to work with ICU patients lying in a variety of positions in order to make the tool generalizable to everyday ICU settings.

They further noted that their approach would benefit by additional monitoring of patients’ consciousness, as those closer to wakefulness are more likely to accidentally endanger their own safety.

Still, their novel use of facial recognition software to improve care of woozy patients shows promise.

“We were surprised about the high degree of accuracy that we achieved, which shows that this new technology has the potential to be a useful tool for improving patient safety,” Sato said.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.